Anyone who has been touched by cancer knows that life after a diagnosis is never the same.
Survivors face many challenges, and our health care system simply isn’t geared to help people live well after the treatments are completed.
Elevating Survivorship is a patient-led initiative to improve survivorship care in the United States. Through Elevate, NCCS highlights gaps in survivorship care, improves survivorship care at the local level, and educates audiences about the need for survivorship care.
Suggestions or questions? Contact us email@example.com.
Grant funding for Elevating Survivorship provided by: Bristol-Myers Squibb, Janssen Oncology, Pharmacyclics, Eisai and Takeda Oncology.